MC1785A1 - VECTORS FOR EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS - Google Patents

VECTORS FOR EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS

Info

Publication number
MC1785A1
MC1785A1 MC86FR8600153D MC1785D MC1785A1 MC 1785 A1 MC1785 A1 MC 1785A1 MC 86FR8600153 D MC86FR8600153 D MC 86FR8600153D MC 1785 D MC1785 D MC 1785D MC 1785 A1 MC1785 A1 MC 1785A1
Authority
MC
Monaco
Prior art keywords
hirudin
secretion
vectors
expression
transformed yeasts
Prior art date
Application number
MC86FR8600153D
Other languages
French (fr)
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of MC1785A1 publication Critical patent/MC1785A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Instructional Devices (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Functional block of DNA enabling to prepare hirudine from yeast, characterized in that it comprises at least: - the gene of hirudine or one of its variants (gene H); - A DNA sequence (Str) comprising the signals providing for the transcription of the gene H by the yeast.
MC86FR8600153D 1985-05-02 1986-05-02 VECTORS FOR EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS MC1785A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8506672A FR2593518B1 (en) 1985-05-02 1985-05-02 VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS
PCT/FR1986/000153 WO1986006406A1 (en) 1985-05-02 1986-05-02 Vectors for the expression and secretion of hirudin by transformed yeasts

Publications (1)

Publication Number Publication Date
MC1785A1 true MC1785A1 (en) 1987-09-02

Family

ID=9318888

Family Applications (1)

Application Number Title Priority Date Filing Date
MC86FR8600153D MC1785A1 (en) 1985-05-02 1986-05-02 VECTORS FOR EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS

Country Status (23)

Country Link
EP (1) EP0200655B1 (en)
JP (2) JP2580141B2 (en)
KR (1) KR870700234A (en)
AT (1) ATE121778T1 (en)
AU (1) AU600667B2 (en)
BG (1) BG49717A3 (en)
CA (1) CA1341501C (en)
CZ (1) CZ282928B6 (en)
DE (1) DE3650306T2 (en)
DK (1) DK174837B1 (en)
ES (1) ES8703930A1 (en)
FI (1) FI104635B (en)
FR (2) FR2593518B1 (en)
HK (1) HK1006183A1 (en)
HU (1) HU202919B (en)
IE (1) IE67136B1 (en)
MC (1) MC1785A1 (en)
NO (1) NO302375B1 (en)
PL (1) PL155074B1 (en)
PT (1) PT82490B (en)
RU (1) RU1774950C (en)
WO (1) WO1986006406A1 (en)
ZA (1) ZA863261B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738541A1 (en) * 1987-11-13 1989-05-24 Hoechst Ag METHOD FOR INSULATING AND CLEANING HIRUDINE
FR2593518B1 (en) * 1985-05-02 1989-09-08 Transgene Sa VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
FR2607516B2 (en) * 1986-12-01 1989-12-22 Transgene Sa IMPROVED VECTORS FOR EXPRESSING A HIRUDIN VARIANT IN YEAST, PROCESS AND PRODUCT OBTAINED
MC1834A1 (en) * 1986-07-10 1988-06-03 Transgene Sa DNA FUNCTIONAL BLOCK AND PLASMID ENCODING HIRUDINE, TRANSFORMED YEAST, PROCESS FOR PREPARING HIRUDINE, HIRUDINE OBTAINED AND ITS USE
FR2607517B2 (en) * 1986-12-01 1989-12-22 Transgene Sa VECTORS FOR EXPRESSING HIRUDIN VARIANTS IN YEAST, PROCESS AND PRODUCT OBTAINED
FR2611723B1 (en) * 1987-02-27 1989-09-08 Transgene Sa RECOMBINANT DNA EXPRESSION VECTOR ENCODING HIRUDINE, INFECTED OR TRANSFORMED MAMMALIAN CELL CULTURES, PROCESS FOR PREPARING HIRUDINE AND PROTEIN OBTAINED
EP0371041A1 (en) * 1987-06-24 1990-06-06 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
DE3819079A1 (en) * 1988-06-04 1989-12-07 Hoechst Ag HIRUDINE DERIVATIVES WITH DELAYED EFFECT
WO1990001063A1 (en) * 1988-07-23 1990-02-08 Delta Biotechnology Limited New secretory leader sequences
DE3835815A1 (en) * 1988-10-21 1990-04-26 Hoechst Ag NEW ISOHIRUDINE
US5053453A (en) * 1988-11-01 1991-10-01 Baxter International Inc. Thromboresistant materials and methods for making same
CA2000887A1 (en) * 1988-11-01 1990-05-01 Cecilia S.L. Ku Thromboresistant materials and methods for making same
FR2646437B1 (en) * 1989-04-28 1991-08-30 Transgene Sa NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME
DE4009268A1 (en) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind SECRETION OF HIRUDIN DERIVATIVES
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
DE4140381A1 (en) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De NEW SYNTHETIC ISOHIRUDINE WITH IMPROVED STABILITY
EP1031628A1 (en) * 1992-09-04 2000-08-30 Novartis AG Process for the production of protease inhibitors
ZA954983B (en) * 1994-06-17 1996-02-14 Novo Nordisk As N-terminally extended proteins expressed in yeast
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
DE19529997C1 (en) 1995-08-16 1997-04-10 Hoechst Ag A method for inactivating carboxypeptidase Y in hirudin-containing culture broths
DE19543737A1 (en) * 1995-11-24 1997-05-28 Hoechst Ag Process for the ultrafiltration of biological matrices containing peptides or proteins
DE19544233A1 (en) 1995-11-28 1997-06-05 Hoechst Ag Process for using the yeast ADH II promoter system for the biotechnological production of heterologous proteins in high yields
ZA9610456B (en) * 1995-12-20 1997-06-20 Novo Nordisk As N-terminally extended proteins expressed in yeast
DE69625623T2 (en) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Method of manufacturing semiconductor device encapsulated in epoxy resin
US6265204B1 (en) * 1997-01-17 2001-07-24 Genencor International, Inc. DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE10149678A1 (en) 2001-10-09 2009-03-12 Novel Science International Gmbh New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin
DE10301255A1 (en) 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organic compounds with biological action as thrombin inhibitors and their use
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382547D1 (en) * 1983-01-12 1992-05-27 Chiron Corp SECRETORIC EXPRESSION IN EUKARYOTS.
AU572125B2 (en) * 1983-03-17 1988-05-05 Mabco Limited Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
JPS60501140A (en) * 1983-04-22 1985-07-25 アムジエン Secretion of exogenous polypeptides by yeast
JPS6041487A (en) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド Use of alpha factor arrangement in yeast development system
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
JPS59227899A (en) * 1983-05-25 1984-12-21 チロン・コ−ポレイシヨン Manufacture of growth hormone release factor
CA1341417C (en) * 1984-03-27 2003-01-21 Paul Tolstoshev Hirudine-expressing vectors, altered cells, and a process for hirudine preparation
ATE64956T1 (en) * 1984-06-14 1991-07-15 Ciba Geigy Ag PROCESS FOR THE PRODUCTION OF THROMBINE INHIBITORS.
DE3429430A1 (en) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt GENE TECHNOLOGICAL METHOD FOR PRODUCING HIRUDINE AND MEANS FOR IMPLEMENTING THIS METHOD
DE3445517C2 (en) * 1984-12-13 1993-11-18 Ciba Geigy DNA sequence coding for a hirudin-like protein and method for producing a hirudin-like protein
FR2593518B1 (en) * 1985-05-02 1989-09-08 Transgene Sa VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS

Also Published As

Publication number Publication date
FI865303A0 (en) 1986-12-23
ZA863261B (en) 1986-12-30
CZ321786A3 (en) 1997-07-16
FI865303A (en) 1986-12-23
DK634386D0 (en) 1986-12-30
FR2601383B2 (en) 1989-12-22
FR2593518A1 (en) 1987-07-31
PT82490B (en) 1988-03-03
EP0200655A1 (en) 1986-11-05
DK174837B1 (en) 2003-12-15
PL155074B1 (en) 1991-10-31
JPH09103295A (en) 1997-04-22
EP0200655B1 (en) 1995-04-26
NO865336L (en) 1987-03-02
FI104635B (en) 2000-03-15
ATE121778T1 (en) 1995-05-15
HK1006183A1 (en) 1999-02-12
CA1341501C (en) 2006-03-14
ES555121A0 (en) 1987-03-16
RU1774950C (en) 1992-11-07
NO302375B1 (en) 1998-02-23
AU5778786A (en) 1986-11-18
HU202919B (en) 1991-04-29
FR2601383A2 (en) 1988-01-15
IE67136B1 (en) 1996-03-06
KR870700234A (en) 1987-05-30
DE3650306D1 (en) 1995-06-01
ES8703930A1 (en) 1987-03-16
BG49717A3 (en) 1992-01-15
IE861183L (en) 1986-11-02
DK634386A (en) 1986-12-30
WO1986006406A1 (en) 1986-11-06
FR2593518B1 (en) 1989-09-08
JPS62502661A (en) 1987-10-15
PT82490A (en) 1986-05-01
JP2779930B2 (en) 1998-07-23
HUT42131A (en) 1987-06-29
DE3650306T2 (en) 1995-10-12
CZ282928B6 (en) 1997-11-12
JP2580141B2 (en) 1997-02-12
AU600667B2 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
FR2593518B1 (en) VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS
ES2056817T5 (en) TRANSFORMATION OF TRICHODERMA.
PH25120A (en) Replicable expression vehicle and process of preparation thereof
MA21169A1 (en) DEOXYRIBONUCLEIC ACIDS AND PROCESS FOR THE PREPARATION OF PROTEINS DERIVED THEREFROM.
DE3863996D1 (en) ALCOHOL-FREE BEER.
ES2108681T3 (en) EXPRESSION OF HUMAN SERUM ALBUMIN IN METHYLTROPHIC YEAST.
ZW2485A1 (en) Cloning of dna for protozoal antigens
FI90667C (en) The method produces a novel human type I interferon protein
FR2607517B2 (en) VECTORS FOR EXPRESSING HIRUDIN VARIANTS IN YEAST, PROCESS AND PRODUCT OBTAINED
IT8883551A0 (en) PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF DNA
ES2078229T3 (en) PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE SIMILAR TO MOTILINE AND ITS EXPRESSION.
AU553409B2 (en) Hybrid vectors and process for improving the amplification and expression of hybrid vectors by use of mitochondrial dna
PT87332A (en) METHOD OF PURIFICATION OF PRODUCT OF EXPRESSION OF RECOMBINANT FERMENT
EP0285361A3 (en) Purification of apase-1 1 and retrieval of the nematode resistance gene
ES2101694T3 (en) EXPRESSION OF PROTEINIC SWEETENERS IN YEAST.
ATE119206T1 (en) DMD PROBE.
IT8621735A0 (en) MICROORGANISCMS MANIPULATED WITH GENETIC ENGINEERING MEANS FOR THE PRODUCTION OF L-AMINO ACIDS.
DK189285D0 (en) (6,11-DIHYDRO-11-OXODIBENZ (B, E) OXEPINYL) -PENTANCARBOXYLIC ACIDS, THEIR PREPARATION AND USE
Kriss p. 103, the last line of the section entitled 5'-Nucleotidase assay should read:/~ mol phosphate released/h per mg protein.
IT8404989V0 (en) JOINT FOR THE TILTING OF AFT WHEELS FOR THE TOWING OF TIRES
TH22943A (en) Recombinant, a protein defining DEV-1 useful for HIV detection, DNA sequencing, protein coding, and immunological analysis using this protein.
IT8641582A0 (en) PROCEDURE AND SYSTEM FOR THE SEPARATION OF PROTEINS FROM LIME WATER AND THE ELIMINATION OF SULPHIDE.
RO89192A2 (en) HONEY LITTLE HIBRID (ZEA MAYS L.CONV.DENTIFORMIS) H.390 LOVRIN
ATE84315T1 (en) RECOMBINANT DNA FOR THE REPLIABLE AND INDUCABLE EXPRESSION OF FOREIGN GENES.